NCT02512575: A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567. |
|
|
| Completed | 1 | 72 | Europe | AZD9567 Monohydrat, Placebo oral suspension/ Placebo capsule, Prednisolone | AstraZeneca | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Healthy Subjects, Rheumatoid Arthritis | 09/16 | 09/16 | | |
